Beta Bionics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Beta Bionics and other ETFs, options, and stocks.About BBNX
Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes.
CEOSean Thomas Saint
CEOSean Thomas Saint
Employees291
Employees291
HeadquartersIrvine, California
HeadquartersIrvine, California
Founded2015
Founded2015
Employees291
Employees291
BBNX Key Statistics
Market cap1.37B
Market cap1.37B
Price-Earnings ratio-17.35
Price-Earnings ratio-17.35
Dividend yield—
Dividend yield—
Average volume1.21M
Average volume1.21M
High today$31.78
High today$31.78
Low today$30.81
Low today$30.81
Open price$31.35
Open price$31.35
Volume148.73K
Volume148.73K
52 Week high$32.71
52 Week high$32.71
52 Week low$8.89
52 Week low$8.89
Stock Snapshot
As of today, Beta Bionics(BBNX) shares are valued at $31.09. The company's market cap stands at 1.37B, with a P/E ratio of -17.35.
As of 2025-12-25, Beta Bionics(BBNX) stock has fluctuated between $30.81 and $31.78. The current price stands at $31.09, placing the stock +0.9% above today's low and -2.2% off the high.
Beta Bionics(BBNX) shares are trading with a volume of 148.73K, against a daily average of 1.21M.
During the past year, Beta Bionics(BBNX) stock moved between $8.89 at its lowest and $32.71 at its peak.
During the past year, Beta Bionics(BBNX) stock moved between $8.89 at its lowest and $32.71 at its peak.
Analyst ratings
90%
of 10 ratingsBuy
90%
Hold
10%
Sell
0%
People also own
Based on the portfolios of people who own BBNX. This list is generated using Robinhood data, and it’s not a recommendation.